Highly active ozonides selected against drug resistant malaria

Lobo, Lis; Sousa, Bruno de; Cabral, Lília; Cristiano, Maria Lurdes Santos; Nogueira, Fátima

http://hdl.handle.net/10400.1/9406

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
9406.pdf		229.46 KB	Adobe PDF	Download

Send Feedback

Authors

Lobo, Lis

Sousa, Bruno de

Cabral, Lília

Cristiano, Maria Lurdes Santos

Nogueira, Fátima

Abstract(s)

Ever increasing multi-drug resistance by Plasmodium falciparum is creating new challenges in malaria chemotherapy. In the absence of licensed vaccines, treatment and prevention of malaria is heavily dependent on drugs. Potency, range of activity, safety, low cost and ease of administration are crucial issues in the design and formulation of antimalarials. We have tested three synthetic ozonides NAC89, LC50 and LCD67 in vitro and in vivo against multidrug resistant Plasmodium. In vitro, LC50 was at least 10 times more efficient inhibiting P. falciparum multidrug resistant Dd2 strain than chloroquine and mefloquine and as efficient as artemisinin (ART), artesunate and dihydroartemisinin. All three ozonides showed high efficacy in clearing parasitaemia in mice, caused by multi-drug resistant Plasmodium chabaudi strains, by subcutaneous administration, demonstrating high efficacy in vivo against ART and artesunate resistant parasites.